Public Shareholders (via NASDAQ IPO)
Biotech Investor · 2 portfolio companies
Portfolio
2
Combined Value
$218.8M
Focus Areas
1
Top Stage
Commercial
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Burning Rock Biotech | $205.9M |
| CytoMed Therapeutics | $12.9M |